Literature DB >> 28564568

Abuse-Deterrent Opioid Formulations - Putting the Potential Benefits into Perspective.

William C Becker1, David A Fiellin1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28564568     DOI： 10.1056/NEJMp1701553

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  15 in total

1.  Assessment of Racial/Ethnic and Income Disparities in the Prescription of Opioids and Other Controlled Medications in California.

Authors:  Joseph Friedman; David Kim; Todd Schneberk; Philippe Bourgois; Michael Shin; Aaron Celious; David L Schriger
Journal:  JAMA Intern Med       Date:  2019-04-01       Impact factor: 21.873

2.  Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids.

Authors:  Abby Alpert; David Powell; Rosalie Liccardo Pacula
Journal:  Am Econ J Econ Policy       Date:  2018-11

3.  Opioid Crisis: No Easy Fix to Its Social and Economic Determinants.

Authors:  Nabarun Dasgupta; Leo Beletsky; Daniel Ciccarone
Journal:  Am J Public Health       Date:  2017-12-21       Impact factor: 9.308

Review 4.  Abuse-Deterrent Opioid Formulations: A Key Ingredient in the Recipe to Prevent Opioid Disasters?

Authors:  Aaron J Salwan; Nicholas E Hagemeier; Sam Harirforoosh
Journal:  Clin Drug Investig       Date:  2018-07       Impact factor: 2.859

Review 5.  Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.

Authors:  Keith Humphreys; Chelsea L Shover; Christina M Andrews; Amy S B Bohnert; Margaret L Brandeau; Jonathan P Caulkins; Jonathan H Chen; Mariano-Florentino Cuéllar; Yasmin L Hurd; David N Juurlink; Howard K Koh; Erin E Krebs; Anna Lembke; Sean C Mackey; Lisa Larrimore Ouellette; Brian Suffoletto; Christine Timko
Journal:  Lancet       Date:  2022-02-02       Impact factor: 202.731

Review 6.  [Pain inhibition by opioids-new concepts].

Authors:  C Stein
Journal:  Anaesthesist       Date:  2019-02       Impact factor: 1.041

7.  Person-level changes in oxycodone use after the introduction of a tamper-resistant formulation in Australia.

Authors:  Andrea L Schaffer; Nicholas A Buckley; Louisa Degenhardt; Briony Larance; Rose Cairns; Timothy A Dobbins; Sallie-Anne Pearson
Journal:  CMAJ       Date:  2018-03-26       Impact factor: 8.262

8.  Is the rise in illicit opioids affecting labor supply and disability claiming rates?

Authors:  Sujeong Park; David Powell
Journal:  J Health Econ       Date:  2021-01-22       Impact factor: 3.804

Review 9.  Managing severe pain and abuse potential: the potential impact of a new abuse-deterrent formulation oxycodone/naltrexone extended-release product.

Authors:  Joseph V Pergolizzi; Robert Taylor; Jo Ann LeQuang; Robert B Raffa
Journal:  J Pain Res       Date:  2018-02-08       Impact factor: 3.133

10.  Oxycodone hydrochloride immediate-release analgesic for managing severe pain: abuse-deterrent formulations.

Authors:  A H Kibbe; T S Franko; V M Shah
Journal:  Ther Clin Risk Manag       Date:  2018-04-30       Impact factor: 2.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.